Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

CNY 7.57

(0.53%)

Net Income Summary of Sichuan Goldstone Asia Pharmaceutical Inc.

  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest annual net income in 2023 was 126.19 Million CNY , down -42.32% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest quarterly net income in 2024 Q3 was 18.92 Million CNY , up 137.39% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported an annual net income of 218.78 Million CNY in 2022, up 229.1% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported an annual net income of 66.48 Million CNY in 2021, up 109.67% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a quarterly net income of 89.81 Million CNY for 2024 Q1, up 813.81% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported a quarterly net income of -50.61 Million CNY for 2024 Q2, down -156.35% from previous quarter.

Annual Net Income Chart of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Historical Annual Net Income of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Year Net Income Net Income Growth
2023 126.19 Million CNY -42.32%
2022 218.78 Million CNY 229.1%
2021 66.48 Million CNY 109.67%
2020 -687.65 Million CNY -671.46%
2019 120.33 Million CNY -19.32%
2018 149.15 Million CNY 28.73%
2017 115.86 Million CNY 353.91%
2016 25.52 Million CNY 9.18%
2015 23.38 Million CNY -27.18%
2014 32.1 Million CNY -34.34%
2013 48.9 Million CNY -14.0%
2012 56.85 Million CNY 5.35%
2011 53.97 Million CNY 0.0%

Peer Net Income Comparison of Sichuan Goldstone Asia Pharmaceutical Inc.

Name Net Income Net Income Difference
China National Complete Plant Import & Export Corporation Limited -262.65 Million CNY 148.047%